Recombinant Human ACVR1B (C-6His)

Description

EnkiLife provides the Recombinant Human ACVR1B (C-6His) protein,aslo know as Activin Receptor Type-1B,Activin Receptor Type IB,ACTR-IB,Activin Receptor-Like Kinase 4,ALK-4,Serine/Threonine-Protein Kinase Receptor R2,SKR2,ACVR1B,ACVRLK4,ALK4, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<1 EU/µg as determined by LAL test.;Construction:Recombinant Human Activin Receptor Type-1B is produced by our Mammalian expression system and the target gene encoding Ser24-Glu126 is expressed with a 6His tag at the C-terminus.Accession:P36896. Expression Host:Human Cells.Species:Human.Predicted Molecular Mass:12.46 KDa. Background:Activin Receptor Type-1B (ACVR1B) is a single-pass type I membrane protein that belongs to the protein kinase superfamily. ACVR1B contains one GS domain and one protein kinase domain and is expressed in many tissues, most strongly in kidney, pancreas, brain, lung, and liver. ACVR1B acts as a transducer of activin or activin like ligands signals. Activin binds to either ACVR2A or ACVR2B and then forms a complex with ACVR1B, ACVR2A or ACVR2B activating ACVR1B through phosphorylation of its regulatory GS domain. They go on to recruit the R-SMADs, SMAD2 and SMAD3. ACVR1B also transducers signals of nodal, GDF-1, and Vg1. Mutations in ACVR1B are associated with pituitary tumors.